UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D

Diabetes care, 2020-12, Vol.43 (12), p.2991-2998

2020

Volltextzugriff (PDF)

Efficacy and Safety of Ultra-Rapid Lispro in Younger and Older Patients with Type 2 Diabetes: Randomized Double-Blind PRONTO-T2D Study

Diabetes therapy, 2022-08, Vol.13 (8), p.1547-1557

2022

Volltextzugriff (PDF)

Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial

The Lancet (British edition), 2024-09, Vol.404 (10458), p.1132-1142

2024

Volltextzugriff (PDF)

Aging and insulin secretion

American journal of physiology: endocrinology and metabolism, 2003-01, Vol.284 (1), p.E7-E12

2003

Volltextzugriff (PDF)

Does peritoneal lavage influence the rate of complications following pediatric Laparoscopic Appendicectomy in Children with Complicated Appendicitis? A Prospective Randomized Clinical Trial

Journal of pediatric surgery, 2019-12, Vol.54 (12), p.2524-2527

2019

Volltextzugriff (PDF)

Fasting and postprandial plasma glucose contributions to hemoglobin A1c and time in range in people with diabetes on multiple daily injection insulin therapy: Results from the PRONTO-T1D and PRONTO-T2D clinical trials

Journal of diabetes and its complications, 2024-01, Vol.38 (1), p.108648-108648, Article 108648

2024

Volltextzugriff (PDF)

Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes

PloS one, 2014-09, Vol.9 (9), p.e106537-e106537

2014

Volltextzugriff (PDF)

Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5

Diabetes care, 2016-01, Vol.39 (1), p.92-100

2016

Volltextzugriff (PDF)

107-LB: Relative Contribution of Fasting Plasma and Postprandial Glucose to HbA1c and TIR in People with T1D on Basal-Bolus Insulin Therapy

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Short-Term Exercise Improves β-Cell Function and Insulin Resistance in Older People with Impaired Glucose Tolerance

The journal of clinical endocrinology and metabolism, 2008-02, Vol.93 (2), p.387-392

2008

Volltextzugriff (PDF)

Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes

Diabetes therapy, 2023-11, Vol.14 (11), p.1933-1945

2023

Volltextzugriff (PDF)

Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range

Diabetes therapy, 2023-05, Vol.14 (5), p.883-897

2023

Volltextzugriff (PDF)

The GLP-1 Derivative NN2211 Restores β-Cell Sensitivity to Glucose in Type 2 Diabetic Patients After a Single Dose

Diabetes (New York, N.Y.), 2003-07, Vol.52 (7), p.1786-1791

2003

Volltextzugriff (PDF)

Relationship of Glucose Variability With Glycated Hemoglobin and Daily Mean Glucose: A Post Hoc Analysis of Data From 5 Phase 3 Studies

Journal of diabetes science and technology, 2018-03, Vol.12 (2), p.325-332

2018

Volltextzugriff (PDF)

Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials

Diabetes, obesity & metabolism, 2016-11, Vol.18 (11), p.1093-1097

2016

Volltextzugriff (PDF)

Dose Unit Establishment for a New Basal Insulin Using Joint Modeling of Insulin Dose and Glycemic Response

Journal of diabetes science and technology, 2018-01, Vol.12 (1), p.155-162

2018

Volltextzugriff (PDF)

Performance of an Electronic Diary System for Intensive Insulin Management in Global Diabetes Clinical Trials

Diabetes technology & therapeutics, 2015-08, Vol.17 (8), p.571-579

2015

Volltextzugriff (PDF)

Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials

Diabetes, obesity & metabolism, 2016-11, Vol.18 (11), p.1089-1092

2016

Volltextzugriff (PDF)

Time-Averaged Self-Monitored Blood Glucose Values Estimate Hemoglobin A1c Outcomes in Patients With Type 1 Diabetes

Journal of diabetes science and technology, 2018-07, Vol.12 (4), p.905-906

2018

Volltextzugriff (PDF)

Impaired β-Cell Function in Human Aging: Response to Nicotinic Acid-Induced Insulin Resistance

The journal of clinical endocrinology and metabolism, 2006-09, Vol.91 (9), p.3303-3309

2006

Volltextzugriff (PDF)

Derivation, external and clinical validation of a deep learning approach for detecting intracranial hypertension

NPJ digital medicine, 2024-09, Vol.7 (1), p.233-7, Article 233

2024

Volltextzugriff (PDF)

Cytokeratin-18 and enhanced liver fibrosis scores in type 1 and type 2 diabetes and effects of two different insulins

Journal of investigative medicine, 2018-03, Vol.66 (3), p.661-668

2018

Volltextzugriff (PDF)

Effects of hepato-preferential basal insulin peglispro on nuclear magnetic resonance biomarkers lipoprotein insulin resistance index and GlycA in patients with diabetes

Biomarkers in medicine, 2017-11, Vol.11 (11), p.991-1001

2017

Volltextzugriff (PDF)

Congenital hernia of umbilical cord masquerading as umbilical cyst and omphalocele on antenatal scans

Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2020, Vol.13 (3), p.285-287

2020

Volltextzugriff (PDF)

1046-P: Effect of Age on HbA1c, Postprandial Glucose (PPG) Control, and Hypoglycemia in Patients with T2D Treated with Ultra-Rapid Lispro (URLi) or Humalog: PRONTO-T2D

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

1 – 25 von 517

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(476)
Mit Volltextzugriff
(462)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neuro-Oncology
(69)
Journal Of Clinical Oncology
(14)
Neurosurgery
(13)
Nature Genetics
(10)
Diabetes
(8)
Neurosurgery/neurosurgery Online
(8)
Cancer Epidemiology, Biomarkers & Prevention
(7)
Nature
(7)
Blood
(6)
Cancer
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D

Efficacy and Safety of Ultra-Rapid Lispro in Younger and Older Patients with Type 2 Diabetes: Randomized Double-Blind PRONTO-T2D Study

Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial

Aging and insulin secretion

Does peritoneal lavage influence the rate of complications following pediatric Laparoscopic Appendicectomy in Children with Complicated Appendicitis? A Prospective Randomized Clinical Trial

Fasting and postprandial plasma glucose contributions to hemoglobin A1c and time in range in people with diabetes on multiple daily injection insulin therapy: Results from the PRONTO-T1D and PRONTO-T2D clinical trials

Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes

Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5

107-LB: Relative Contribution of Fasting Plasma and Postprandial Glucose to HbA1c and TIR in People with T1D on Basal-Bolus Insulin Therapy

Short-Term Exercise Improves β-Cell Function and Insulin Resistance in Older People with Impaired Glucose Tolerance

Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes

Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range

The GLP-1 Derivative NN2211 Restores β-Cell Sensitivity to Glucose in Type 2 Diabetic Patients After a Single Dose

Relationship of Glucose Variability With Glycated Hemoglobin and Daily Mean Glucose: A Post Hoc Analysis of Data From 5 Phase 3 Studies

Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials

Dose Unit Establishment for a New Basal Insulin Using Joint Modeling of Insulin Dose and Glycemic Response

Performance of an Electronic Diary System for Intensive Insulin Management in Global Diabetes Clinical Trials

Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials

Time-Averaged Self-Monitored Blood Glucose Values Estimate Hemoglobin A1c Outcomes in Patients With Type 1 Diabetes

Impaired β-Cell Function in Human Aging: Response to Nicotinic Acid-Induced Insulin Resistance

Derivation, external and clinical validation of a deep learning approach for detecting intracranial hypertension

Cytokeratin-18 and enhanced liver fibrosis scores in type 1 and type 2 diabetes and effects of two different insulins

Effects of hepato-preferential basal insulin peglispro on nuclear magnetic resonance biomarkers lipoprotein insulin resistance index and GlycA in patients with diabetes

Congenital hernia of umbilical cord masquerading as umbilical cyst and omphalocele on antenatal scans

1046-P: Effect of Age on HbA1c, Postprandial Glucose (PPG) Control, and Hypoglycemia in Patients with T2D Treated with Ultra-Rapid Lispro (URLi) or Humalog: PRONTO-T2D

Suchergebnisse filtern